de-risked pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique Biologics CDMO providing biological drug development ...

Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZeneca.

de-risked pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique Biologics CDMO providing biological drug development ...

The antibody is called VHH (Variable Heavy domain of a Heavy chain-only antibody) and will be designed to target four potential pandemic influenza virus strains—H1, H3, H5 and H7. According to CEPI, ...

Scinai Immunotherapeutics Ltd. , a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and in providing CDMO services through its Scinai Bioservices unit, ...

For decades, traditional affinity purification platforms like Protein A have been the cornerstone of monoclonal antibody manufacturing. However, the rise of engineered modalities – including ...